$TXHD ~ The growth in SMS mobile text marketing has been

New Post Public Reply Private Reply Replies (0) Message Board
zigzagman
$TXHD ~ The growth in SMS mobile text marketing has been grabbing the attention of investors as the old world of email promotion makes way for the new world, which is promotion offers right to your phone.

According to research by The Wireless Association, the open rate of text promotions/offers is a whopping 98%, while the open rate of emails is a just 22%. An email might sit in a customer’s inbox all day, but people’s phones will sit in their pockets or even better in their hand, and are much more likely to see the promotion then with email. This makes text a read within minutes, making it a great channel for flash sales and same-day promotions.

This explosion in SMS mobile text marketing has put a bullish light on stocks within this arena. One of the bigger players, Twilio (NYSE:TWLO) offers contextual SMS marketing by embedding messaging, voice, and video capabilities directly into their software applications. Founded in 2008,Twilio has over 650 employees, and currently trades at a $2.6 billion market cap after their successful IPO in June 2016. www.twilio.com

A smaller player within this sector gaining attention is Textmunication Holdings (OTCMKTS:TXHD), which develops an online mobile marketing platform service that also helps customers communicate with their members by allowing them to build loyalty, engage member retention, and create new business through a non-intrusive, value added medium. Clients on TXHD platform can send their most up-to-date offers, discounts, member alerts, events, PT schedules, or any other personalized campaign.

The potential for this market has been grabbing the attention of investors in recent months. Ludlow Research, an small cap equity research firm based out of New York City, just today added TXHD to their trader “watch list” based on the company’s low market capital valuation, and potential market growth.

In a note to their subscribers, Ludlow commented that with around 180 million shares issued and outstanding, and their growing base of vertical clients and revenue operations, the company may provide a value trade based on a market cap of only around $180,000 at a price of $0.0009 per share. They added with the retirement of prior toxic notes, and growing interest in SMS mobile marketing, they gave TXHD stock a “speculative” target of $0.02 per share, or conservative $4 million market valuation.

http://www.wallstreetnewscast.com/txhd-1220/#...uR0Z1.dpbs
Scroll down for more posts ▼

Top 10 Most Recent News Articles

GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 5

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading
Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 4

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 6

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 6

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading
PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 4

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading
Surfing Dogs Ride Waves, Support Orphan Pets

Updated Category News Views 3

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Continue Reading
First-Time Homeowners: Unseen Pitfalls of Insurance

Updated Category News Views 5

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 12

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading
UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 2

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading

Top 5 Most Recently Viewed Articles

Chinese Stock Markets Experience Significant Decline Amidst Concerns

Updated Category News Views 46

Chinese Stock Markets Experience Significant Decline Mainland China stock markets opened sharply lower, resulting in the end of a promising 10-day winning streak. This downturn followed analysts and investors expressing skepticism toward government efforts aimed at implementing stimulus plans designed to invigorate the economy. Market Indices Performance As trading began,...

Continue Reading
Celebrating the Leadership Transition at the International Myeloma Foundation

Updated Category News Views 153

A Leadership Transition at the International Myeloma Foundation In a heartfelt announcement, the International Myeloma Foundation (IMF) recently shared the news that Mr. Yelak Biru will be stepping down from his role as President and CEO. After three years at the helm, Mr. Biru's departure marks the beginning of a new chapter for the organization. Mr. Biru's Last Day with...

Continue Reading
Navigating Retirement Savings for High-Income Earners

Updated Category News Views 82

How High-Income Earners Approach Retirement Savings For many, achieving a secure retirement is closely tied to their income level. High-income earners are in a distinct position, equipped with substantial resources. This financial edge not only enables them to save more but also opens doors to various investment opportunities that can significantly boost wealth....

Continue Reading
Anticipating Exxon Mobil's Earnings Release This November

Updated Category News Views 67

Anticipating Exxon Mobil's Earnings Release Exxon Mobil (NYSE: XOM) is set to unveil its quarterly earnings report soon, and anticipation is building among investors. With analysts predicting an earnings per share (EPS) of $1.96, many are eager to see how the company performs against these expectations. In the world of investing, guidance often plays a crucial role....

Continue Reading
Empowering Data Privacy: INE Security Celebrates Awareness Week

Updated Category News Views 104

Celebrating Data Privacy Week: INE Security's Commitment As we observe Data Privacy Week, INE Security stands at the forefront, championing the significance of robust data protection techniques. This year's theme, "Take Control of Your Data," sends a powerful message about the necessity of managing personal information as our lives become increasingly digital. With every...

Continue Reading